Phyllanthus spp. Exerts Anti-Angiogenic and Anti-Metastatic Effects Through Inhibition on Matrix Metalloproteinase Enzymes

Nutrition and Cancer

Volumn 67, Issue 5, 2015, Pages 783-795

  Tang, Yin Quan ^a   Jaganath, Indu Bala ^b   Manikam, Rishya ^a   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MALAYSIAN AGRICULTURAL RESEARCH AND DEVELOPMENT INSTITUTE MARDI   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLANT EXTRACT;

CELL ADHESION; CELL MOTION; CHEMISTRY; DRUG EFFECTS; HUMAN; MALE; METABOLISM; PHYLLANTHUS; PRECLINICAL STUDY; PREVENTION AND CONTROL; TUMOR CELL LINE; TUMOR INVASION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PHYLLANTHUS; PLANT EXTRACTS;

EID: 84934434261     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1040518     Document Type: Article

References (43)

1. Cancer Research UK: Skin Cancer Incidence Statistics. England, 2012.
2. American Cancer Society: Melanoma Skin Cancer. United States, 2012.
3. Hew K: Prostate Cancer. Malaysian Oncological Society, 2012.
4. Bernhard EJ, Gruber SB, and Muschel RJ: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proceedings of the National Academy of Sciences 91, 4293-4297, 1994.
5. Itoh Y and Nagase H: Matrix metalloproteinases in cancer. Essays Biochem 38, 21-36, 2002.
6. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407, 249-257, 2000.
7. Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Academic Press: Seminars in cancer biology, 2010.
8. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2, 161-174, 2002.
9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al.: Global cancer statistics. CA: A Cancer Journal for Clinicians 61, 69-90, 2011. doi:10.3322/caac.20107
10. Jilaveanu LB, Aziz SA, and Kluger HM: Chemotherapy and biologic therapies for melanoma: Do they work? Clinics in Dermatology 27, 614-625, 2009.
11. Tang YQ, Jaganath IB, and Sekaran SD: Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis. PLoS One 5, e12644, 2010. doi:10.1371/journal.pone.0012644
12. Calixto JB, Santos ARS, and Yunes RA: A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential. Medicinal Research Reviews 18, 225-258, 1998.
13. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, et al.: 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. International Journal of Cancer 65, 57-62, 1998.
14. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, et al.: Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clinical Cancer Research 10, 7621-7628, 2004.
15. Sier C, Kubben F, Ganesh S, Heerding M, Griffioen G, et al.: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. British Journal of Cancer 74, 413, 1996.
16. Kerbel RS: Tumor angiogenesis: Past, present and the near future. Carcinogenesis 21, 505-515, 2000.
17. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, et al.: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical cancer research 14, 4491-4499, 2008.
18. Nakachi K, Matsuyama S, Miyake S, Suganuma M, and Imai K: Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention. Biofactors 13, 49-54, 2008.
19. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al.: Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Research 24, 2783-2840, 2004.
20. Tan G, Gyllenhaal C, and Soejarto D: Biodiversity as a source of anticancer drugs. Current Drug Targets 7, 265-277, 2006.
21. Huang ST, Yang RC, Lee PN, Yang SH, Liao SK, et al.: Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma. International Immunopharmacology 6, 870-879, 2006.
22. Stetler-Stevenson WG, Aznavoorian S, and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annual Review of Cell Biology 9, 541-573, 1993.
23. Lee S, Desai KK, Iczkowski KA, Newcomer RG, Wu KJ, et al.: Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Research 16, 750-758, 2006.
24. Zhao YG, Xiao AZ, Newcomer RG, Park HI, Kang T, et al.: Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. Journal of Biological Chemistry 278, 15056-15064, 2003.
25. Cai Y, Luo Q, Sun M, and Corke H: Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sciences 74, 2157-2184, 2004.
26. Saetung A, Itharat A, Dechsukum C, Wattanapiromsakul C, Keawpradub N, et al.: Cytotoxic activity of Thai medicinal plants for cancer treatment. Songklanakarin Journal of Science and Technology 27, 471-478, 2005.
27. Sun J and Hai Liu R: Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Letters 241, 124-134, 2006. doi:10.1016/j.canlet.2005.10.027
28. Tang Y-Q, Jaganath I, Manikam R, and Sekaran SD: Phyllanthus Suppresses prostate cancer cell, PC-3, proliferation and induces apoptosis through multiple signalling pathways (MAPKs, PI3K/Akt, NF B, and Hypoxia). Evidence-Based Complementary and Alternative Medicine 2013, 2013.
29. Lopes FC, Rocha A, Pirraco A, Regasini LO, Silva DH, et al.: Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. BMC Complementary and Alternative Medicine 9, 15, 2009.
30. Eun JP and Koh GY: Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochemical and Biophysical Research Communications 317, 618-624, 2004.
31. Kruczynski A, Poli M, Dossi R, Chazottes E, Berrichon G, et al.: Antiangiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development. European Journal of Cancer 42, 2821-2832, 2006.
32. Ho HH, Chang CS, Ho WC, Liao SY, Wu CH, et al.: Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kB activity and downregulation of PI3K/AKT/small GTPase signals. Food and Chemical Toxicology 48, 2508-2516, 2010.
33. Lu Y, Jiang F, Jiang H, Wu K, Zheng X, et al.: Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. European Journal of Pharmacology 641, 102-107, 2010.
34. Liu KC, Huang AC, Wu PP, Lin HY, Chueh FS, et al.: Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and-9 signaling pathways. Oncology Reports 26, 177, 2011.
35. Tseng HH, Chen PN, Kuo WH, Wang JW, Chu SC, et al.: Antimetastatic Potentials of Phyllanthus urinaria L on A549 and Lewis Lung Carcinoma Cells via Repression of Matrix-Degrading Proteases. Integrative Cancer Therapies 11, 267-278, 2012.
36. Weng C-J, Chau C-F, Hsieh Y-S, Yang S-F, and Yen G-C: Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kB and AP-1. Carcinogenesis 29, 147-156, 2008.
37. Adya R, Tan BK, Punn A, Chen J, and Randeva HS: Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: Novel insights into visfatin-induced angiogenesis. Cardiovascular Research 78, 356-365, 2008.
38. Ma J, Sawai H, Ochi N, Matsuo Y, Xu D, et al.: PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Molecular and cellular biochemistry 331, 161-171, 2009.
39. Nakashio A, Fujita N, and Tsuruo T: Topotecan inhibits VEGF-and bFGF-induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway. International Journal of Cancer 98, 36-41, 2001.
40. Jin UH, Lee JY, Kang SK, Kim JK, Park WH, et al.: A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: Isolation and identification from methanol extract of Euonymus alatus. Life Sciences 77, 2760-2769, 2005.
41. He B, Hu M, Li S-D, Yang X-T, Lu Y-Q, et al.: Effects of geraniin on osteoclastic bone resorption and matrix metalloproteinase-9 expression. Bioorganic & Medicinal Chemistry Letters, 630-634, 2012.
42. Vijayababu M, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, et al.: Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Molecular and Cellular Biochemistry 287, 109-116, 2006.
43. Kamalakkannan N and Prince P: The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney. Journal of Pharmacy and Pharmacology 58, 1091-1098, 2006.